Loading...

Cresco Labs Inc.

CRLBF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.97
$0.05(5.47%)
U.S. Market opens in 14h 23m

Cresco Labs Inc. (CRLBF) Stock Overview

Explore Cresco Labs Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap321.8M
P/E Ratio-2.31
EPS (TTM)$-0.38
ROE-0.33%
Fundamental Analysis

AI Price Forecasts

1 Month$0.72
3 Months$1.36
1 Year Target$0.53

CRLBF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cresco Labs Inc. (CRLBF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.59, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.53.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.31 and a market capitalization of 321.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
5.59%
5-Day Change
6.10%
1-Month Change
0.11%
3-Month Change
-28.23%
6-Month Change
-30.77%
Year-to-Date (YTD) Change
-20.64%
1-Year Change
58.61%
3-Year Change
-33.45%
5-Year Change
-91.76%
All-Time (Max) Change
-80.33%

Contact Information

https://www.crescolabs.com
312 929 0993
400 West Erie Street, Chicago, IL, 60654

Company Facts

2,900 Employees
IPO DateDec 3, 2018
CountryUS
Actively Trading

Frequently Asked Questions